Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels

Peer Review reports

Original Submission
12 Sep 2013	Submitted	Original manuscript
12 Mar 2014	Reviewed	Reviewer Report - Fredric O Finkelstein
13 Mar 2014	Reviewed	Reviewer Report - Mae Thamer
17 Apr 2014	Author responded	Author comments - Katherine Cappell
Resubmission - Version 2
17 Apr 2014	Submitted	Manuscript version 2
2 May 2014	Reviewed	Reviewer Report - Fredric O Finkelstein
6 May 2014	Reviewed	Reviewer Report - Mae Thamer
22 May 2014	Author responded	Author comments - Katherine Cappell
Resubmission - Version 3
22 May 2014	Submitted	Manuscript version 3
Publishing
30 Jun 2014	Editorially accepted
11 Jul 2014	Article published	10.1186/1471-2369-15-116

Back to article page